
Loading, please wait...

Loading, please wait...

Borophene, a single layer of boron atoms, has recently captured the attention of the scientific community. This material exhibits a unique anisotropy in its crystallographic structure. Consequently, it demonstrates diverse physical and chemical behaviors. Borophene in biomedical applications is a growing field because of the material's high electronic mobility and chemical reactivity. While researchers have already explored metallic β and semiconducting α phases, new crystallographic phases are currently under investigation. These variations allow for specialized uses in next-generation medical devices.
Despite its potential, borophene faces significant hurdles before widespread clinical use. The synthesis process remains cumbersome and hinders the large-scale production of defect-free layers. Furthermore, the material is highly sensitive to oxidation and suffers from phase instability. Scientists are now implementing strategies like defect engineering and surface functionalization to address these issues. Additionally, 2D-2D hybridization offers a path for tuning the band gap and improving carrier injection. These refinements are essential for creating stable sensors and imaging tools.
Integration into medical devices involves resolving issues such as interfacial charging and work function mismatch. However, if researchers overcome these barriers, borophene could transform multiple specialties. Specifically, it holds promise for flexible batteries in wearable monitors and advanced biosensors for point-of-care diagnostics. Furthermore, its high surface area makes it an ideal candidate for targeted drug delivery systems. Therefore, the ongoing research into borophene stability is crucial for its eventual commercialization in the healthcare sector.
Borophene is lighter, more flexible, and possesses higher electronic mobility than graphene. These properties allow for more sensitive detection of biological molecules at trace levels.
Currently, researchers are studying its biocompatibility. Strategies like surface passivation and functionalization are being developed to reduce toxicity and prevent rapid oxidation in biological environments.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional services. Always seek the advice of your physician or other qualified health provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Li Z et al. Borophene: Crucial Challenges and the Way Forward. Adv Sci (Weinh). 2026 Mar 15. doi: 10.1002/advs.202517082. PMID: 41833012.
Pan D et al. Chiralized Borophene for Biomedical Imaging and Targeted Delivery. ACS Nano. 2024 May 8. doi: 10.1021/acsnano.4c01792.
Blundell R. Revolutionary materials in medicine: Borophene, graphene, and graphite. Independent Malta. 2024 June 23.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A review of borophene's unique properties, current synthesis challenges, and its transformative potential in biomedical sensors and drug delivery....
4 months ago

Data from the RASolute-302 trial and ASCO 2026 demonstrate that the pan-RAS inhibitor daraxonrasib doubles overall survival in second-line metastatic pancreatic cancer, ushering in a novel era of allele-specific and combination targeted strategies.
Today

A photovoice study in Elmhurst, Queens explores how low-income immigrant pregnant women express maternal resilience through nature, family bonds, community resources, and psychological reframing, providing vital insights for strengths-based prenatal care.
Today

A cross-sectional study at Hoima Regional Referral Hospital in Western Uganda examined the prevalence and associated risk factors of atrial fibrillation among adults with type 2 diabetes mellitus, highlighting key clinical predictors and implications for cardiovascular screening.
Today

A retrospective cohort study evaluated an extended medial approach with medial femoral epicondyle osteotomy for severe medial tibial plateau fractures, demonstrating comparable radiographic and functional outcomes to standard approaches.
Today

Preclinical toxicology of an equimolar D-beta-hydroxybutyrate (D-BHB) formulation for long-chain fatty acid oxidation disorders established a minipig NOAEL of 500 mg/kg BID (1000 mg/kg/day). Key acute findings included transient hypertension, tachycardia, QTc prolongation, and diarrhea at high doses.
Today